MDSpire - MDSpire Home

MDSpire - MDSpire Home

Region

United States US publications and network International Global sites and content

The premier global destination for healthcare professionals looking for trusted clinical content, breaking news, and a wealth of educational resources.

Conexiant.com
Conexiant Education

Trusted by leading healthcare organizations to deliver measurable engagement, education, and brand growth.

Conexiant Solutions
Conexiant DXP

MDSpire is an innovative platform aiming to create a smarter, faster, and more connected medical community.

MDSpire.com
DentalSpire.com

Association Partner

Our vision is a world free from digestive diseases. That's why it's our mission to empower clinicians and researchers to improve digestive health.

gastro.org
agau.org.gastro
myaga.gastro.org
foundation.gastro.org
agajournals.org
healthecareers.com

Conexiant.com
Conexiant Education

Conexiant DXP

MDSpire.com
DentalSpire.com

gastro.org
myaga.gastro.org
agajournals.org
agau.org.gastro
foundation.gastro.org

Advertisement

What is MDSpire?

MDSpire is an innovative platform aiming to create a smarter, faster, and more connected medical community.

Learn More

Choose specialties Cardiology Dermatology Endocrinology Family Medicine Gastroenterology Hematology Internal Medicine Neurology ObGyn Oncology Ophthalmology Optometry Pediatrics Rheumatology Pulmonary Psychiatry Pathology Surgery Orthopedic Medicine Radiology Otolaryngology Infectious Disease

May 26, 2026

Semaglutide Reduced Nicotine Craving in Small Trial

Andrea Surnit
May 26, 2026
4 min

Takeaways
Insight Report
Quiz
Poll
Top Thought Leaders

Semaglutide reduced nicotine craving and body weight in smokers, but did not significantly decrease cigarettes smoked per day.
The trial involved 24 non-treatment-seeking adults who smoked at least 5 cigarettes daily, assigned to semaglutide or placebo for 9 weeks.
Participants receiving semaglutide lost about 5% of body weight, while those on placebo experienced a slight weight increase.
Exploratory analyses indicated semaglutide may reduce withdrawal symptoms and increase smoking abstinence self-efficacy.
The study's small size and short duration limit the generalizability of findings, particularly for broader smoking cessation efforts.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Discover top thought leaders in a clinical topic, with data-driven rankings and expert profiles highlighting their influence and contributions.

Explore Experts

The Analytical Scientist

May 26, 2026

Spectroscopy Roundup: Water, Interfaces, and Asteroids

May 26, 2026
8 min

Summary
Insight Report
Quiz

Objective: To summarize recent advancements in spectroscopy techniques and their applications in studying confined water, battery degradation, droplet chemistry

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

The Pathologist

May 26, 2026

Leading Pathology’s Digital Evolution

Jessica Allerton
May 26, 2026
6 min

Summary
Takeaways
Insight Report
Poll
Top Thought Leaders

Objective: Revise to include direct attribution. Key Findings: Ensure findings are directly sourced. Interpretation: Remove or rephrase to avoid unsupported con

Pathology integrates clinical information, morphology, and molecular data to provide accurate diagnoses that influence treatment and patient outcomes.
Digital pathology, AI, and expanded diagnostic testing are creating opportunities for innovation and translational research in the field.
Innovation in pathology must align with clinical practice to avoid disrupting workflows and increasing cognitive burden for pathologists.
Careful validation and monitoring of AI tools are critical to address challenges such as dataset bias and algorithm drift.
Future pathologists should embrace lifelong learning, technology, and ethical standards while collaborating to advance the field.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Discover top thought leaders in a clinical topic, with data-driven rankings and expert profiles highlighting their influence and contributions.

Explore Experts

The Pathologist

May 26, 2026

Lipidomics Point to Obesity–Alzheimer's Link

May 26, 2026
2 min

Summary
Insight Report
Poll
Clinical Scorecard

Objective: To investigate obesity-related changes in lipid metabolism and their potential contribution to the development and progression of Alzheimer's disease

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

The Medicine Maker

May 26, 2026

This Week’s Biopharma News: ADCs, Biosimilars, and Microbiome Moves

May 26, 2026
9 min

Summary
Takeaways
Insight Report
Poll
Clinical Scorecard

Objective: To summarize recent developments in biopharmaceuticals, including clinical trial results and regulatory updates. Key Findings: Sac-TMT met primary en

Merck's sacituzumab tirumotecan met phase 3 endpoints in advanced endometrial cancer, showing improved overall and progression-free survival.
Microbiotica's MB097, a microbiome therapy, demonstrated positive phase 1b results in advanced melanoma when combined with pembrolizumab.
Akeso's ligufalimab, an anti-CD47 monoclonal antibody, showed a survival signal in phase 2 trials for treatment-naïve acute myeloid leukemia.
Regeneron's phase 3 trial of fianlimab and cemiplimab in melanoma did not achieve statistical significance for progression-free survival.
The FDA finalized guidance on postapproval pregnancy safety studies to enhance safety data collection for drugs and biologics used during pregnancy.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

The Ophthalmologist

May 26, 2026

FDA Clears Nocturnal IOP Device

May 26, 2026
2 min

Summary
Insight Report
Quiz
Clinical Scorecard

Objective: To announce the FDA 510(k) clearance of the FSYX Ocular Pressure Adjusting Pump (OPAP) for lowering intraocular pressure during sleep in adults with

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

The Ophthalmologist

May 26, 2026

Refocusing Retinal Imaging

May 26, 2026
4 min

Summary
Insight Report
Quiz

Objective: To propose a method that combines hardware adaptive optics optical coherence tomography (AO-OCT) with computational aberration correction (CAC) to ex

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

The Medicine Maker

May 26, 2026

Infrastructure at Scale: A Conversation with Germfree’s New CEO

May 26, 2026
9 min

Summary
Insight Report
Quiz
Clinical Scorecard

Objective: To discuss the challenges and strategies in scaling manufacturing for advanced therapies in the pharmaceutical industry. Key Findings: The science of

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Frontiers In Immunology

May 26, 2026

Therapeutic targeting of lysosome-triggered inflammatory channels in nasal and upper-airway allergic conditions

Haoran Yu
Yujin Zheng
Daquan Wu
Lei Zhou
Kanglun Jiang
Kaisai Tian
Na Shen
May 26, 2026

Summary
Takeaways
Insight Report
Quiz
Poll

Objective: To summarize the role of lysosome-triggered inflammatory pathways in nasal and upper airway allergic conditions, particularly allergic rhinitis and r

Nasal and upper airway allergic disorders significantly impact global health, causing symptoms that impair quality of life and increase healthcare costs.
Lysosomes play a crucial role in airway inflammation by activating immunological signaling and releasing pro-inflammatory cytokines through calcium signaling.
The NLRP3 inflammasome is a key player in allergic inflammation, promoting the release of IL-1β and macrophage pyroptosis in the nasal mucosa.
Targeting lysosomal ion channels, such as TPCs and TRPML, offers promising therapeutic strategies to reduce inflammation and systemic side effects.
Re-evaluating lysosomes as active signaling hubs opens new avenues for precision-based therapies in allergic airway inflammation.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Immunology

May 26, 2026

Precision immunopharmacology in peri-implantitis management: from molecular mechanisms to advanced therapeutic strategies

Yong Chen
Qing Yuan
MingWang Cui
ZhuLing Guo
May 26, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To review the evolving shift in peri-implantitis research from traditional mechanical debridement toward host-modulatory and immunopharmacological co

Peri-implantitis is an immunologically complex condition, necessitating a shift from mechanical debridement to host-modulatory therapies.
Emerging therapeutic strategies include targeted anti-cytokine biologics and macrophage-directed approaches, though most are still in preclinical stages.
Advanced drug delivery systems, such as stimuli-responsive hydrogels, may enhance localized treatment for peri-implantitis.
Single-cell RNA sequencing has revealed distinct immune microenvironment characteristics in peri-implantitis compared to healthy tissues.
Future management of peri-implantitis may rely on immunopharmacological strategies, biomarker diagnostics, and artificial intelligence for personalized care.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Pediatrics

May 26, 2026

Partly intraoperative cell salvage in pediatric craniocerebral trauma: effects on coagulation function, allogeneic blood requirements, and clinical outcomes — a propensity score-matched retrospective cohort study

Chao Wang
Lijing Li
Zhengzheng Gao
Jing Hu
Fang Wang
May 26, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To determine whether partial intraoperative autologous blood reinfusion alters postoperative coagulation function compared with allogeneic transfusio

Partial intraoperative cell salvage (ICS) reduces allogeneic blood consumption in pediatric craniocerebral trauma patients.
The incidence of postoperative coagulation disorders is significantly lower in the ICS group compared to the allogeneic blood transfusion (ABL) group.
No significant differences in standard coagulation indices or electrolyte balance were observed between the ICS and ABL groups after propensity score matching.
Hypofibrinogenemia was less frequent in the ICS group, indicating better coagulation status compared to the ABL group.
Clinical outcomes such as operating time and hospital stay did not differ significantly between the ICS and ABL groups.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Immunology

May 26, 2026

Immune regulation and cell metabolism in B cell subsets in patients with systemic lupus erythematosus

Masanobu Ueno
Satoshi Kubo
Yasuyuki Todoroki
Shingo Nakayamada
Yoshiya Tanaka
May 26, 2026

Summary
Takeaways
Insight Report
Quiz
Clinical Scorecard

Objective: Emphasize the significance of metabolic regulation in SLE pathogenesis. Key Findings: Include context on the implications of findings for future rese

Systemic lupus erythematosus (SLE) is an autoimmune disease primarily affecting young women and involving multiple organ systems.
Autoreactive B cells play a crucial role in SLE by mediating antibody production, antigen presentation, and cytokine secretion.
Immunometabolism is a key regulatory mechanism influencing B cell activation, differentiation, and the pathogenesis of SLE.
Disruption of B-cell tolerance mechanisms in SLE leads to increased autoreactive B cells and excessive autoantibody production.
Recent advancements in B-cell targeted therapies, such as belimumab and rituximab, show promise in managing SLE and reducing glucocorticoid dependence.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Frontiers In Oncology

May 26, 2026

Case Report: Cutaneous niche-restricted malignant phenotypes in PTCL-NOS revealed by single-cell sequencing

Shucheng Zhang
Zhuqing Li
Yang Lin
Xiaoyue Sun
Meng Qiao
Xiaoqing Si
May 26, 2026

Summary
Insight Report
Quiz

Objective: To investigate the tissue-specific molecular mechanisms driving cutaneous aggression in PTCL-NOS using single-cell RNA sequencing, highlighting the s

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

May 26, 2026

Ebola outbreak continues to worsen, with new collateral risks for girls and women

Theresa Gaffney
May 26, 2026

Summary
Takeaways
Insight Report
Quiz
Clinical Scorecard

Objective: To report on the worsening Ebola outbreak in the Democratic Republic of Congo and its implications for women and girls. Key Findings: Add source attr

The Ebola outbreak in the Democratic Republic of Congo has 101 confirmed cases and over 900 suspected cases, with 10 confirmed deaths.
The outbreak has spread to Uganda, prompting Rwanda to issue a travel ban for individuals who have been in the DRC recently.
Public health experts warn that Ebola outbreaks increase the risk of violence, particularly affecting women and girls.
The estimated number of people living with a mental disorder globally in 2023 is 1.17 billion, nearly double the number in 1990.
Eight former CDC directors advocate for the preservation of PEPFAR, emphasizing its critical role in saving lives and disease surveillance.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Jama Network Open

May 26, 2026

Global Aid Cuts and Local Health Consequences in Nakivale Refugee Settlement, Uganda

HaEun Lee
Camilla Bjelland
Kay Wallace
Donath Asiimire
Fred Sheldon Mwesigwa
May 26, 2026

Summary
Takeaways
Insight Report
Quiz

Objective: To explore health care practitioners' lived experiences, challenges, and adaptive strategies in Nakivale refugee settlement amid significant funding

Global Development Assistance for Health has drastically decreased from $80.3 billion in 2021 to a projected $38.4 billion in 2025.
USAID cuts in 2025 will result in a $307 million loss for Uganda, leading to a 66% reduction in health programs.
The Nakivale refugee settlement, home to over 274,000 refugees, faces severe health care challenges due to funding cuts.
Projected health outcomes include 14 million additional deaths by 2030, with significant impacts on women and children.
This qualitative study captures health care practitioners' experiences and challenges in Nakivale amid unprecedented funding reductions.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Frontiers In Endocrinology

May 26, 2026

Adiponectin and leptin levels in mothers, fetuses, and neonates with intrauterine growth restriction compared to those with appropriate gestational age

Nuzhat Parveen
Naveed Iqbal
Abdelrahim Awadelkarim Abdelrahman Mohamed
Syed Monowar Alam Shahid
Rania Abdeen Hussain Abdalla
Gamal Eldin Mohamed Osman Elhussein
Mohammad Asim Azhar
Mohd. Saleem
Mohd Shahid Khan
May 26, 2026

Summary
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To evaluate adiponectin and leptin levels in maternal peripheral blood, umbilical cord blood, and neonatal peripheral blood, and to investigate chang

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Oncology

May 26, 2026

Imaging features of lung cancer with cystic airspaces: clinical utility, challenges, and perspectives

Mengyue Hu
Jinbao Feng
Xiaonan Shao
Yunmei Shi
Jianxiong Gao
Yaoting Zhu
Yuhao Fan
Yan Sun
Zhenxing Jiang
Rong Niu
Qianyun Wang
May 26, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To review the definition, underlying mechanisms, and clinical aspects of noninvasive imaging in the diagnosis, classification, invasiveness predictio

Lung cancer with cystic airspaces (LCCA) is a rare subtype, accounting for 1-4% of lung cancer cases, primarily adenocarcinoma.
LCCA presents unique imaging challenges, often overlapping with benign conditions, complicating early diagnosis.
Current guidelines lack standardized protocols for LCCA management, with only Lung-RADS 2022 addressing cystic nodules.
Noninvasive imaging is crucial for preoperative evaluation of LCCA due to high false-negative rates in invasive procedures.
The article reviews advances in imaging modalities for LCCA, emphasizing the need for improved diagnostic and prognostic strategies.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Immunology

May 26, 2026

ANXA2 promotes NLRP3 inflammasome activation and neuronal pyroptosis after intracerebral hemorrhage

Qingyuan Wu
Yuetao Wen
Yiqing Shen
XiangYu Chen
WenSong Yang
Limin Ma
Peng Xie
May 26, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To investigate the role of Annexin A2 (ANXA2) in NLRP3 inflammasome activation and neuronal pyroptosis after intracerebral hemorrhage (ICH), highligh

Intracerebral hemorrhage (ICH) is a severe stroke type that lacks effective pharmacotherapy, contributing to high mortality and neurological deficits.
Pyroptosis, driven by NLRP3 inflammasome activation, significantly contributes to neuronal death following ICH.
ANXA2 was identified as a key hub protein that regulates NLRP3 inflammasome activation and neuronal pyroptosis after ICH.
Silencing ANXA2 reduced NLRP3 activation, decreased inflammatory cytokine secretion, and improved neurological outcomes in ICH models.
The study highlights a novel ANXA2–NLRP3–pyroptosis pathway, suggesting potential therapeutic targets for mitigating secondary brain injury after ICH.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Advertisement

Advertisement

Advertisement

About
Privacy Policy

Follow Us

Author/Creator Name

[Credentials]

[Current title or role]

Affiliations: [Institution, organization]

Specialties: Oncology Hematology

View Full Profile

Contributions:

[brand name]

Content Title Goes Here and it Will Get Clamped at Two line

[author name] July 23, 2025 5 min

[brand name]

Content Title Goes Here and it Will Get Clamped at Two line

[author name] July 23, 2025 5 min

[brand name]

Content Title Goes Here and it Will Get Clamped at Two line

[author name] July 23, 2025 5 min

Show all